I'm still trying to absorb what happened in the last 30
I'm still trying to absorb what happened in the last 30 minute of the market.
I am very disappointed in the build up that GC gave us leading to both Copenhagen and this conference. The company's communication is crap, just crap.
It seems now that the delay of news at Copenhagen wasn't because they wanted to "showcase" LymPro at today's conference. It was the "oh shit, the data isn't ready, but hopefully it will be by the Summit" so push ut off with a plausible excuse. Then that shell game failed and we get what happened yesterday and today.
Right now, my confidence in GC is shot. My trust is shaken and unless there is a surprise coming, I don't see how we uplist in Q4 without destroying the rest of our value.
Absolutely horrible. Partnership for LymPro? Why would any company partner for this?
Again, I just hope that something will come out that is not yet public. Today was an absolute horror show and I can't blame the overall market for it.
Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Arianna Huffington's Experience with Overworking Arianna Huffington is widely recognized for launching The Huffington Post news website in 2005. However, her journey took a significant turn just two years later when she suffered a collapse in her office due to extreme exhaustion and lack of sleep. This pivotal moment compelled Huffington to rethink the culture of...
Continue Reading
Understanding Public Opening Position Disclosures In the realm of financial markets, ensuring transparency is crucial. Public opening position disclosures allow market participants to learn about the interests of individuals and entities in significant securities. One such disclosure recently made headlines as Rathbones Group Plc announced its positions in Learning...
Continue Reading
Todd Graves launched Raising Cane's back in 1996, defying critics who claimed a chicken finger-only menu wouldn’t fly. I mean, come on—banks tossed him aside like last week's stale fries when he tried to secure funding. Imagine that skepticism ringing through Louisiana's south: all they saw was a niche that couldn’t possibly sustain itself. But here’s the kicker:...
Continue Reading
Exploring the Growth of Orla Mining Investments Orla Mining has shown remarkable performance in the stock market, with an annual increase of 5.29% compared to the wider market over the past five years, delivering an average annual return of 18.92%. Investors are certainly intrigued by the growth factors contributing to a market capitalization of $3.65 billion. Investment...
Continue Reading
Celestica's Announcement for Q3 2025 Financial Results Celestica Inc. (TSX and NYSE: CLS) is gearing up for its third quarter 2025 financial results conference call and an exciting Investor and Analyst Day. The scheduled call will take place on a Tuesday morning soon after the market closes, providing valuable insights to participants. Conference Call Details The...
Continue Reading